These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. There are the trees; the subject lesson of "NSAID gastropathy". Roth SH J Rheumatol; 1991 Apr; 18(4):629-30. PubMed ID: 1898479 [No Abstract] [Full Text] [Related]
24. Prophylaxis of nonsteroidal antiinflammatory drug gastropathy: a clinical opinion. Roth SH; Fries JF; Abadi IA; Hubscher O; Mintz G; Samara AM J Rheumatol; 1991 Jul; 18(7):956-8. PubMed ID: 1920327 [No Abstract] [Full Text] [Related]
25. Prophylaxis and treatment of NSAID-induced gastropathy. Ament PW; Childers RS Am Fam Physician; 1997 Mar; 55(4):1323-6, 1331-2. PubMed ID: 9092293 [TBL] [Abstract][Full Text] [Related]
26. [The NSAID gastropathy--a new hypothesis on the etiology]. Fredholm BB Lakartidningen; 1992 Jul; 89(28-29):2421-2. PubMed ID: 1507955 [No Abstract] [Full Text] [Related]
27. Epidemiology of NSAID-induced gastropathy. Zeidler H Clin Rheumatol; 1991 Dec; 10(4):369-73. PubMed ID: 1802489 [No Abstract] [Full Text] [Related]
28. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations? Chen JT; Pucino F; Resman-Targoff BH J Pain Palliat Care Pharmacother; 2006; 20(4):11-32. PubMed ID: 17182503 [TBL] [Abstract][Full Text] [Related]
29. The aging stomach: implications for NSAID gastropathy. Lee M; Feldman M Gut; 1997 Oct; 41(4):425-6. PubMed ID: 9391235 [No Abstract] [Full Text] [Related]
30. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs. Vakil N Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894 [TBL] [Abstract][Full Text] [Related]
31. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs]. Houben JJ; Liem B Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2338. PubMed ID: 10589225 [No Abstract] [Full Text] [Related]
33. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Singh G Am J Med; 1998 Jul; 105(1B):31S-38S. PubMed ID: 9715832 [TBL] [Abstract][Full Text] [Related]
34. [NSAID-induced damage to the gastrointestinal mucosa]. Rodonezhskaia EV; Kharchenko NV Lik Sprava; 2001; (4):179-80. PubMed ID: 11692710 [TBL] [Abstract][Full Text] [Related]
35. [COMORBIDITY AND POLYMORBIDITY IN ADULTS AND CHILDREN IN THE LIGHT OF THE PROBLEM OF NSAID-GASTROPATHY]. Serebrova YUS; Prokofiev AB; Zhuravleva MV; Sichinava IB; Smolyarchuk EA; Galstyan PL; Kurguzova DO; Pankratova NA Eksp Klin Gastroenterol; 2016; (6):80-8. PubMed ID: 30280811 [TBL] [Abstract][Full Text] [Related]
36. [An open study on the efficacy and safety of misoprostol in prevention or treatment of gastroduodenal lesions induced by NSAID: preliminary data]. Passiu G Clin Ter; 1991 Dec 15-31; 139(5-6):191-2. PubMed ID: 1802506 [No Abstract] [Full Text] [Related]
37. Two cases of NSAID-induced gastropathy and enteropathy of the ileum. Auld MC; Dodd BR; Barbour AP; Smithers M ANZ J Surg; 2015; 85(7-8):584-5. PubMed ID: 24251369 [No Abstract] [Full Text] [Related]
38. Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management. Szabo S; Spill WF; Rainsford KD Med Toxicol Adverse Drug Exp; 1989; 4(2):77-94. PubMed ID: 2654544 [No Abstract] [Full Text] [Related]
39. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs]. Fialová P; Vlcek J Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967 [TBL] [Abstract][Full Text] [Related]